Abstract:Although various liver chips have been developed using emerging organ-on-a-chip techniques, it remains an enormous challenge to replicate the liver lobules with self-assembled perfusable hepatic sinusoid networks. Herein we develop a lifelike bionic liver lobule chip (LLC), on which the perfusable hepatic sinusoid networks are achieved using a microflow-guided angiogenesis methodology; additionally, during and after self-assembly, oxygen concentration is regulated to mimic physiologically dissolved levels supplied by actual hepatic arterioles and venules. This liver lobule design thereby produces more bionic liver microstructures, higher metabolic abilities, and longer lasting hepatocyte function than other liver-on-a-chip techniques that are able to deliver. We found that the flow through the unique micropillar design in the cell coculture zone guides the radiating assembly of the hepatic sinusoid, the oxygen concentration affects the morphology of the sinusoid by proliferation, and the oxygen gradient plays a key role in prolonging hepatocyte function. The expected breadth of applications our LLC is suited to is demonstrated by means of preliminarily testing chronic and acute hepatotoxicity of drugs and replicating growth of tumors in situ. This work provides new insights into designing more extensive bionic vascularized liver chips, while achieving longer lasting ex-vivo hepatocyte function.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c00794?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c00794</a>.Design parameters of the engineered liver lobule chip (LLC); fabrication of the PDMS layer for the LLC; components of the LLC platform; key operations of the LLC; percentages of hepatocytes, LSECs, HSCs, and KCs before the loading of the cell-laden collagen; study of medium flow directions through HA and PV of the LLC; design and application of the oxygen concentration regulating chip (ORC); formation of hepatic sinusoids over time; comparison of the metabolic functions of hepatocytes cultured in four modes; hepatic plates and sinusoids on Day 14; associated arrangements of hepatic plates and sinusoids; venules crossing the gap between micropillars; confirmation of bile canaliculi; cell staining for the cell distribution and viability under various flow rates and related statistics; changes in the metabolic functions of hepatocytes after 14 days at flow rates of 25, 50, and 75 μL/min; cell staining for the cell distribution and viability under various dissolved oxygen concentrations and related statistics; changes in the metabolic functions of hepatocytes after 14 days at a flow rate of 50 μL/min under the three designated conditions; preliminary experiments for the acute hepatotoxicity testing of the drugs APAP and INH; effects of medium flow rates on extracellular matrix (ECM) heights; effects of the medium change frequencies on the metabolic functions of hepatocytes (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c00794/suppl_file/am1c00794_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System

Dynamic Liver Chip Based on Well-Coupled Microfluidics: An Accurate NASH Model for Drug Evaluation

Customized liver organoids as an advanced in vitro modeling and drug discovery platform for non-alcoholic fatty liver diseases

Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease

Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease

Hydrogel Microfluidic‐based Liver‐on‐a‐chip: Mimicking the Mass Transfer and Structural Features of Liver

Mice Hepatic Organoids for Modeling Nonalcoholic Fatty Liver Disease and Drug Response

A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression

Validation of an adipose-liver human-on-a-chip model of NAFLD for preclinical therapeutic efficacy evaluation

A Liver-Chip-based Alcoholic Liver Disease Model Featuring Multi-Non-parenchymal Cells.

Ginsenoside Rb1 Improves Human Nonalcoholic Fatty Liver Disease with Liver Organoids-on-a-chip

On-Chip Construction of Liver Lobules with Self-Assembled Perfusable Hepatic Sinusoid Networks

Human Liver Organoid: Modeling Liver Steatosis and Beyond

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis

A human liver chimeric mouse model for non-alcoholic fatty liver disease

Gut–liver on a chip toward an in vitro model of hepatic steatosis

State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC.

Bioengineering scalable and drug-responsive in vitro human multicellular non-alcoholic fatty liver disease microtissues encapsulated in the liver extracellular matrix-derived hydrogel

Microfluidic models in liver drug metabolism research